Montag & Associates’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$845 Buy
+2
New +$531 ﹤0.01% 932
2025
Q2
– Sell
-50
Closed -$2.98K – 1035
2025
Q1
$2.98K Hold
50
– – ﹤0.01% 871
2024
Q4
$6.62K Hold
50
– – ﹤0.01% 817
2024
Q3
$2.62K Sell
50
-400
-89% -$18.8K ﹤0.01% 902
2024
Q2
$27.2K Buy
450
+400
+800% +$27.7K ﹤0.01% 675
2024
Q1
$3.71K Buy
+50
New +$3.71K ﹤0.01% 836

Other funds holding ALAB

Montag & Associates's ALAB Position: Q2 2026 in Review

Montag & Associates opened a new position in Astera Labs (ALAB) in Q2 2026: 2 shares worth $845. The stake represents ﹤0.01% of the portfolio and ranks #932 among its holdings. This is a return to the name: Montag & Associates previously reported a position in ALAB as recently as Q1 2025.

Montag & Associates first reported a position in ALAB in Q1 2024 and has held it in 6 quarters since. The position peaked at $27.2K in Q2 2024. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Montag & Associates held 2 shares of Astera Labs worth $845 as of Q2 2026.
  • Astera Labs was a new Montag & Associates position in Q2 2026.
  • Astera Labs made up ﹤0.01% of Montag & Associates's portfolio in Q2 2026, its #932 holding.
  • Montag & Associates first reported a position in Astera Labs in Q1 2024 and has held it in 6 quarters since.
  • Montag & Associates's Astera Labs position peaked at $27.2K in Q2 2024.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.